Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2006
05/30/2006CA2158826C Process for the preparation of urea
05/30/2006CA2157668C Tricyclic 2,3,4,5-tetrahydro-1h-3-benzazepines, their use and preparation
05/26/2006WO2006055841A2 Indefinite culture of human adult glia without immortalization and therapeutic uses thereof
05/26/2006WO2006055187A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar
05/26/2006WO2006054757A1 Caspase inhibitor
05/26/2006WO2006054652A1 Amide compound
05/26/2006WO2006053707A1 Novel derivatives of porphyrin, particularly chlorins and/or bacteriochlorins, and uses thereof in photodynamic therapy
05/26/2006WO2006024486A3 Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
05/26/2006WO2006004636A3 Fused heterocyclic kinase inhibitors
05/26/2006WO2005123737A3 Charge-transport materials, methods of fabrication thereof, and methods of use thereof
05/26/2006CA2588513A1 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
05/26/2006CA2585172A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar
05/26/2006CA2584619A1 Amide compound
05/25/2006US20060111569 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
05/25/2006US20060111568 Novel azo dye compound
05/25/2006US20060111567 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
05/25/2006US20060111565 Oxo-bacteriopyropheophorbide-a carboxylic acid and esters thereof
05/25/2006US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione
05/25/2006US20060111419 Novel fused indazole compounds
05/25/2006US20060111416 Octahydropyrrolo[3,4-C]pyrrole derivatives
05/25/2006US20060111387 Immonomoderators; viricides; anticancer agents; for example, 2-Butyl-1-isobutyl-7-(thiophen-3-yl)-1H-imidazo[4,5-c]quinolin-4-amine; use of these compounds for inducing or inhibiting cytokine biosynthesis in animals
05/25/2006US20060111374 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders
05/25/2006US20060111373 Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists
05/25/2006US20060111372 Alkyl-substituted pyrazolopyrimidines
05/25/2006US20060111362 1,3-Dihydroimidazole ring compound
05/25/2006US20060111356 External preparation for allergic diseases
05/25/2006US20060111337 Substituted biaryl quinolin-4-ylamine analogues
05/24/2006EP1659124A1 Pyrrolotriazole compound
05/24/2006EP1659123A1 Bicyclic pyrazole derivative
05/24/2006EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
05/24/2006EP1658292A1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
05/24/2006EP1658290A2 Compounds and compositions as protein kinase inhibitors
05/24/2006EP1373225B1 Process for coupling amino acids to an antifolate scaffold
05/24/2006EP1363912B1 Substituted imidazotriazinones
05/24/2006EP1334106B1 Imidazole derivatives, production method thereof and use thereof
05/24/2006EP1259520B1 Novel purines
05/24/2006DE102004044884A1 Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen Substituted bicyclic imidazo-3-yl-amine compounds
05/24/2006CN1777610A Water-soluble mono-pegylated tetrapyrrole derivatives for photodynamic therapy and method of production
05/24/2006CN1777609A 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
05/24/2006CN1777608A Fused pyrimidine derivative
05/24/2006CN1777607A Substituted 8 -pyridinyl-dihydrospiro- cycloalkyl -pyrimido 1,2-a pyrimidin-6-one and 8 -pyrimidin yl-dihydrospiro- cycloalkyl -pyrimido 1,2-a pyrimidin-6-one derivatives
05/24/2006CN1777606A 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo [2, 3d]pyrimidine hydrogen mesylate and its polymorphic forms
05/24/2006CN1777605A Cannabined receptor ligands and uses thereof
05/24/2006CN1777603A Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
05/24/2006CN1257169C Bicyclic imidazo-3-yl-amine derivatives
05/23/2006US7049437 Particularly a crystal of 2-(3-isoxazolyl)-3,6,7,9-tetrahydroimidazo(4,5-d) pyrano(4,3-b)pyridine phosphate monohydrate
05/23/2006US7049320 Drugs for treating physiological disorder, respiratory disorders, inflammatory disease, skin disorder, and antidepressants, treating bipolar disorder, drug abuse, drug dependence, gastrointestinal disorder, atherosclerosis
05/23/2006US7049318 1-Benzyl-2-(5-benzylamino-1-methyl-6-oxo-4-pyridin-4-yl-1,6-dihydro-pyrimidin-2-ylamino)-ethyl]-(S)-carbamic acid tert-butyl ester or derivatives
05/23/2006US7049315 Solubilized topoisomerase poisons
05/23/2006US7049311 Pyrrolbenzodiazepines
05/23/2006US7049310 Therapy for bacteria infections
05/23/2006US7048909 Aerosols containing nondegraded atenolol, pindolol, esmolol, propranolol, or metoprolol
05/18/2006WO2006053121A2 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity
05/18/2006WO2006053024A2 Lactam compounds and their use as pharmaceuticals
05/18/2006WO2006052962A2 Bicyclic triazole a4 integrin inhibitors
05/18/2006WO2006052913A1 PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES
05/18/2006WO2006052378A1 Constrained compounds as cgrp-receptor antagonists
05/18/2006WO2006051704A1 Imine compound
05/18/2006WO2006050976A1 Azaindole carboxamides
05/18/2006WO2006050946A1 1,4 substituted pyrazolopyrimidines as kinase inhibitors
05/18/2006WO2006050803A1 Substituted bi- and tricyclic pyrazol-derivatives, method for the production and use thereof as herbicides and plant growth regulators
05/18/2006WO2006041773A3 Lactam compounds useful as protein kinase inhibitors
05/18/2006WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof
05/18/2006US20060107141 Database mining system and method for coverage analysis of functional verification of integrated circuit designs
05/18/2006US20060106041 Synthesis of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole (YC-1) as anti-platelet agents
05/18/2006US20060106035 Phenyl-substituted pyrazolopyrimidines
05/18/2006US20060106033 Pyrazolopyridines and methods of making and using the same
05/18/2006US20060106032 selective inhibitor of protease activated receptor (PAR)-4-dependent activation; inhibits low thrombin-induced Ca++ signal and thromboxane production; inhibit vascular endothelial growth factor induced cell proliferation, migration, tube formation in human umbilial vein endothelial cells; antitumor agent
05/18/2006US20060106023 Novel imidazopyrazines as cyclin dependent kinase inhibitors
05/18/2006US20060106022 Imidazo[4,5-b]pyrazinone inhibitors of protein kinases
05/18/2006US20060106020 Tetracyclic inhibitors of Janus kinases
05/18/2006US20060106019 Novel substituted pyrazolo[1,5 a]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same
05/18/2006US20060106008 Pharmaceutical use of fused 1,2,4-triazoles
05/18/2006US20060106007 N-((hetero)arylalkyl)pyrimidonecarboxamides in which the ring is fused to a C4-7(hetero)cycloalkyl ring, which in turn has a spiro ring attached: e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-8'-methyl-4'-oxo-spiro[cyclopentane-1,9'(6'H)-[4H]pyrazino[1,2-a]pyrimidine]-2'-carboxamide
05/18/2006DE102004054665A1 Substituierte bi- und tricyclische Pyrazol-Derivate Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren Substituted bi- and tricyclic pyrazole derivatives A process for the preparation and use as herbicides and plant growth regulators
05/18/2006CA2587667A1 Imine compound
05/18/2006CA2587192A1 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity
05/18/2006CA2586375A1 Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
05/18/2006CA2586370A1 Constrained compounds as cgrp-receptor antagonists
05/18/2006CA2585797A1 Lactam compounds and their use as pharmaceuticals
05/18/2006CA2585660A1 1,4 substituted pyrazolopyrimidines as kinase inhibitors
05/18/2006CA2575668A1 Azaindole carboxamides
05/17/2006EP1656383A1 4-biphenyl-substituted 4-substituted pyrazolidin-3,5-diones pesticide agent and/or microbicide and/or herbicide
05/17/2006EP1656382A2 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives
05/17/2006EP1656379A1 4-cycloalkylaminopyrazolo pyrimidine nmda/nr2b antagonists
05/17/2006EP1656373A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokineantagonists
05/17/2006EP1656370A2 Biaryl heterocyclic compounds and methods of making and using the same
05/17/2006EP1656366A1 Substituted pyrimdinone derivatives and methods of use
05/17/2006EP1656353A1 Gabanergic modulators
05/17/2006EP1656350A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists
05/17/2006EP1656345A1 Cyclic derivatives as modulators of chemokine receptor activity
05/17/2006EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
05/17/2006EP1423391B1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
05/17/2006EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors
05/17/2006EP1280555B1 Pharmaceutical composition comprising furosemide and conivaptan for the treatment of congestive heart failure